Belgian Journal of Medical Oncology (BJMO)

To BJMO Specials

The Belgian Journal of Medical Oncology (BJMO) is the official journal of the Belgian Society of Medical Oncology (BSMO) and the Belgian Association for Cancer Research (BACR). BJMO is the journal for training of medical specialists working in the field of oncology, as well as radiotherapists, oncologic surgeons and other internal medicine specialists working in Oncology.

BJMO is a practical and informative medical journal. The aim of the journal is to provide insight and overview of the latest medical developments. Through BJMO, one is informed quickly about the latest relevant developments for clinical practice in medical oncology and related fields. The content is compiled by an independent editorial board, written by medical specialists, and is peer-reviewed in order to warrant objective information.

Of course, BJMO is open to contributions from readers. Spontaneous submissions can be published after review and approval by the editorial board. More information about submissions is available at Submission of manuscripts.

For articles from BJMO, check: www.bjmo.be or click on the cover.

To other Journals

Editorial Board

CHAIRMAN EDITORIAL BOARD

J. De Grève, MD, PhD, Professor in Oncology, head of department of medical oncology, University Hospital Brussels, Brussels

FOUNDED BY

L. Dirix, MD, PhD, medical oncologist, St Augustinus Hospital, Wilrijk

EDITORIAL BOARD

A. Awada, MD, PhD, Professor in Oncology, Jules Bordet Institute, Brussels
J-F. Baurain, MD, PhD, Professor in Oncology, Cliniques Universitaires Saint-Luc, Brussels
F. Cornelis, MD, medical oncologist, Cliniques Universitaires Saint-Luc, Brussels
H. Denys, MD, PhD, medical oncologist, University Hospital Gent, Gent
M. De Ridder, MD, PhD, Professor in Radiation Oncology, UZ Brussel, Brussels
M. Dicato, MD, haematologist-oncologist, Centre Hospitalier de Luxembourg, Luxembourg
P. Dirix, MD, PhD, radiation oncologist, University Hospitals Leuven, Leuven v
L. Duck, MD, PhD, medical oncologist, Clinique Saint-Pierre, Ottignies

C. Duhem, MD, haematologist-oncologist, Centre Hospitalier de Luxembourg, Luxembourg
F. Duhoux, MD, PhD, medical oncologist, Cliniques Universitaires Saint-Luc, Brussels
A. Hendrix, MD, medical oncologist, Gent University Hospital, Gent
G. Jerusalem, MD, PhD, medical oncologist, CHU Sart-Tilman, Liège
J. Kerger, MD, PhD, medical oncologist, Jules Bordet Institute, Brussels
J-P. Machiels, MD, PhD, Professor in Oncology, Cliniques Universitaires Saint-Luc, Brussels
J. Mebis, MD, PhD, medical oncologist, Jessa Ziekenhuis, Hasselt
P. Pauwels, MD, PhD, pathologist, University Hospital Antwerp, Edegem
H. Prenen, MD, PhD, Professor in Oncology, University Hospitals Leuven, Leuven
S. Rottey, MD, PhD, medical oncologist, Gent University Hospital, Gent
P. Specenier, MD, PhD, Professor in Oncology, University Hospital Antwerp, Edegem
J-L. Van Laethem, MD, PhD, Professor in Gastroenterology, Université Libre de Bruxelles, Brussels
H. Van Poppel, MD, PhD, Professor in Urology, University Hospitals Leuven, Leuven
D. Verhoeven, MD, PhD, medical oncologist, AZ KLINA, Brasschaat
J.B. Vermorken, MD, PhD, Professor in Oncology, University Hospital Antwerp, Edegem
H. Wildiers, MD, PhD, Professor in Oncology, University Hospitals Leuven, Leuven